| Schedule of Antidilutive Shares |
The following table summarizes potential common shares that were excluded as their effect is anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Preferred shares outstanding | 6,734,080 | | | — | | | 6,734,080 | | | — | | | Options and unvested stock units outstanding | 749,562 | | | 19,753 | | | 749,562 | | | 19,753 | | | Warrants outstanding | 4,076,371 | | | 1,036,983 | | | 4,076,371 | | | 1,036,983 | | | Convertible promissory notes | 1,580,647 | | | — | | | 1,580,647 | | | — | | | Unvested shares related to VLD MSA | 477,455 | | | — | | | 477,455 | | | — | | | Contingent Sponsor Earnout Shares | 2,054 | | | 2,054 | | | 2,054 | | | 2,054 | | | Total | 13,620,169 | | | 1,058,790 | | | 13,620,169 | | | 1,058,790 | |
|